The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial (370599)

ARTG ID 370599

ARTG Name

SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial

Product name

SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial

ARTG Date

9 August 2021

Registration Type

Medicine

Therapeutic good type

Medicine

Ingredients

elasomeran

Licence category

RE

Licence status

A

Summary

Product Information

Consumer Medicine Information

SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial, Moderna Australia Pty Ltd, CON-891

10 December 2021

Section 14 consent

Consent to while noncompliant with standards. The consent is effective from 10 December 2021 until 9 August 2023.
SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial, Moderna Australia Pty Ltd, CON-960

24 June 2022

Section 14 consent

Consent to while noncompliant with standards. The consent is effective from the 24 June 2022 until 09 August 2023.